Actemra Class Action Lawsuit in 2018 – Green Light Imminent

Drug Injury

Rheumatoid arthritis is a chronic, disabling condition that disproportionately affects more women than men. This condition causes the swelling of joints especially in the wrist, knee, ankle and neck and elbow areas, causing slow bone and cartilage degradation over a number of years. This condition has no known cure, and it is thought to have an autoimmune etiology. The immune system, upon detecting foreign particles around bone joints, sets up an armed attack, obliterating both the “enemy” as well as the compromised bone tissue.  Rheumatoid arthritis is the third most common form of arthritis, and it affects 1 percent of the globe, as well as up to 1.5 million Americans.

Are you looking for an attorney who handles Actemra lawsuits in 2018? If so, please give us a call TODAY at 1 (773) 985-5139 for more information on your legal options for compensation. We can help you recover money damages to help take care of your past and present medical bills, reimburse you for lost wages, pain and suffering and so much more. These cases have a time window within which one must file, so ACT NOW and call us at 1 (773) 985-5139 for your free, confidential and no-commitment consultation today.

What Causes Rheumatoid Arthritis?

Rheumatoid arthritis waxes and wanes. However, it is unrelenting, and slowly gets worse over the years. It is thought that there is a hormonal, genetic or environmental link to this condition, and it may be worse by inclement weather as well as when a person engages in moderate activity or eats a diet high in sugar and refined carbohydrates.

Some of the common symptoms associated with rheumatoid arthritis include:

  1. Stiffness in one’s joints
  2. Swelling and a sensation of heat in these joints
  3. Joint redness
  4. Morning soreness
  5. Pain in both wrists
  6. Fever
  7. Chronic fatigue
  8. Weight loss
  9. Depression and anxiety

Actemra Enters Spotlight

In an attempt to help individuals living with rheumatoid arthritis live a better quality of life by putting their disease into remission, scientists developed an immunosuppressive drug which made its way past FDA regulatory checks, and launched it in 2010. The drug in question is Actemra, and it is prescribed to treat rheumatoid arthritis, giant cell arteritis, as well as other conditions that present with synovial joint inflammation. While there is no question about the efficacy of this medication, it comes with a slew of severe and life-threatening side effects.

Actemra, by virtue of suppressing the immune system response in order to dampen inflammation, leaves the body open to all manner of infections, from fungal, bacterial to viral. Individuals who have taken Actemra may find it difficult to fend off infections even while practicing proper hygiene, and they contract dangerous infections such as tuberculosis and pneumonia. In addition, Actemra has been shown to inflame the pancreas, leading to the development of pancreatitis. On top of that, patients taking Actemra were more likely to suffer heart attacks and stroke, as well as interstitial lung disease and heart failure.

It is alleged that 1,128 have since died from taking Actemra, although other sources have pegged this number to be as much as ten times higher. In addition, statistical analysis which looked at 500,000 side-effect reports showed that individuals taking this immunosuppressant were more likely to suffer cardiovascular events at a much higher rate compared to those that took Humira or Remicade, immunosuppressants that are in direct competition with Actemra.

Some of the side-effects listed on the medication’s packaging include:

  • Hepatitis B
  • Cancer
  • Tears in the gastrointestinal canal
  • Severe allergic reaction

Actemra realized more than $1.7 billion in sales for Roche in 2016, with the drug being prescribed to over 760,000 patients worldwide. Actemra has also been prescribed off-label to treat close to 60 other conditions, something that isn’t in line with FDA recommendations regarding medication use.

Actemra Development – Doctor Raised Alarm Back in 2008

The FDA heard a report by a Boston rheumatologist in 2008, a few years before the drug’s approval regarding the fact that the medication could cause serious heart issues. However, the drug was still given the green light with the contingency that Roche would keep an eye out for the cardiovascular issues caused by their drug via conducting studies several times a year on the same. It is interesting to note that Roche did not place a warning on Actemra boxes regarding this issue.

It was only after 2011 and the deaths of 15 individuals in Japan where the drug was launched that Roche added a warning to its packaging.

Actemra Lawsuit – What are The Accusations Against Roche?

Roche withheld information about the deleterious side effects of its blockbuster arthritis drug. Furthermore, it was accused of engaging in misleading advertising and offering kickbacks to doctors in order to have them prescribe it off-label. It therefore failed in its duty of care towards you, the consumer, when it came to protecting you from any kind of injury that typically is seen when a drug manufacturer is negligent during any of the phases of drug development, marketing and sales.

Actemra Lawsuit Filed By Hundreds – Here’s Your Chance at Compensation

If you’ve been hurt by Actemra, you may be able to recover compensation. We can help you win money damages that will take care of your medical bills, lost wages as well as compensate you for non-economic, abstract damages. We’ve been helping individuals just like you for over 20 years, and we would like to offer this expertise to help you and your family recover justice and compensation as Actemra drug injury attorneys that handle Actemra class action lawsuit concerns. Please call 1 (773) 985-5139 RIGHT NOW to speak with one of our compassionate attorneys today. Thanks, and we look forward to hearing from you.